Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

138 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Development of novel combination therapies.
Woodcock J, Griffin JP, Behrman RE. Woodcock J, et al. Among authors: behrman re. N Engl J Med. 2011 Mar 17;364(11):985-7. doi: 10.1056/NEJMp1101548. Epub 2011 Feb 16. N Engl J Med. 2011. PMID: 21323535 No abstract available.
The FDA's assessment of follow-on protein products: a historical perspective.
Woodcock J, Griffin J, Behrman R, Cherney B, Crescenzi T, Fraser B, Hixon D, Joneckis C, Kozlowski S, Rosenberg A, Schrager L, Shacter E, Temple R, Webber K, Winkle H. Woodcock J, et al. Nat Rev Drug Discov. 2007 Jun;6(6):437-42. doi: 10.1038/nrd2307. Nat Rev Drug Discov. 2007. PMID: 17633790 Review.
Economic issues with follow-on protein products.
Lanthier M, Behrman R, Nardinelli C. Lanthier M, et al. Nat Rev Drug Discov. 2008 Sep;7(9):733-7. doi: 10.1038/nrd2636. Nat Rev Drug Discov. 2008. PMID: 18654570 Review.
FDA regulations for drug development.
Behrman RE, Woodcock J. Behrman RE, et al. Science. 2010 Jul 2;329(5987):33; author reply 33. doi: 10.1126/science.329.5987.33-b. Science. 2010. PMID: 20595600 No abstract available.
138 results